Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Pulmonary toxicities from a 90-day chronic inhalation study with carbon black nanoparticles in rats related to the systemical immune effects.

Chu C, Zhou L, Xie H, Pei Z, Zhang M, Wu M, Zhang S, Wang L, Zhao C, Shi L, Zhang N, Niu Y, Zheng Y, Zhang R.

Int J Nanomedicine. 2019 Apr 30;14:2995-3013. doi: 10.2147/IJN.S198376. eCollection 2019.

2.

Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling.

Wang L, Wang Y, Chen A, Jalali A, Liu S, Guo Y, Na S, Nakshatri H, Li BY, Yokota H.

Int J Oncol. 2018 Sep;53(3):1001-1012. doi: 10.3892/ijo.2018.4481. Epub 2018 Jul 13.

3.

The Impacts of Transportation Infrastructure on Sustainable Development: Emerging Trends and Challenges.

Wang L, Xue X, Zhao Z, Wang Z.

Int J Environ Res Public Health. 2018 Jun 5;15(6). pii: E1172. doi: 10.3390/ijerph15061172. Review.

4.

Attraction and Compaction of Migratory Breast Cancer Cells by Bone Matrix Proteins through Tumor-Osteocyte Interactions.

Chen A, Wang L, Liu S, Wang Y, Liu Y, Wang M, Nakshatri H, Li BY, Yokota H.

Sci Rep. 2018 Apr 3;8(1):5420. doi: 10.1038/s41598-018-23833-1.

5.

Reduction in Migratory Phenotype in a Metastasized Breast Cancer Cell Line via Downregulation of S100A4 and GRM3.

Chen A, Wang L, Li BY, Sherman J, Ryu JE, Hamamura K, Liu Y, Nakshatri H, Yokota H.

Sci Rep. 2017 Jun 14;7(1):3459. doi: 10.1038/s41598-017-03811-9.

6.

The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial.

Boonyawat K, Wang L, Lazo-Langner A, Kovacs MJ, Yeo E, Schnurr T, Schulman S, Crowther MA.

Thromb Haemost. 2016 Aug 30;116(3):480-5. doi: 10.1160/TH16-04-0320. Epub 2016 Jun 23.

PMID:
27346552
7.

[Protective effect of sesamin against myocardial injury induced by cadmium chloride in rats].

Tian J, Zhang R, Zhang H, Liu Y, Niu Y, Zhao L, Wang L, Guo H.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2014 May;32(5):357-60. Chinese.

PMID:
25169091
8.

Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial.

Crowther M, Cook D, Guyatt G, Zytaruk N, McDonald E, Williamson D, Albert M, Dodek P, Finfer S, Vallance S, Heels-Ansdell D, McIntyre L, Mehta S, Lamontagne F, Muscedere J, Jacka M, Lesur O, Kutsiogiannis J, Friedrich J, Klinger JR, Qushmaq I, Burry L, Khwaja K, Sheppard JA, Warkentin TE; PROTECT collaborators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group.

J Crit Care. 2014 Jun;29(3):470.e7-15. doi: 10.1016/j.jcrc.2014.02.004. Epub 2014 Feb 14.

PMID:
24726205
9.

Co-enrollment of critically ill patients into multiple studies: patterns, predictors and consequences.

Cook D, McDonald E, Smith O, Zytaruk N, Heels-Ansdell D, Watpool I, McArdle T, Matte A, Clarke F, Vallance S, Finfer S, Galt P, Crozier T, Fowler R, Arabi Y, Woolfe C, Orford N, Hall R, Adhikari NK, Ferland MC, Marshall J, Meade M; PROTECT Research Coordinators; PROTECT Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care. 2013 Jan 8;17(1):R1. doi: 10.1186/cc11917.

10.

Rates and determinants of informed consent: a case study of an international thromboprophylaxis trial.

Smith OM, McDonald E, Zytaruk N, Foster D, Matte A, Clarke F, Meade L, O'Callaghan N, Vallance S, Galt P, Rajbhandari D, Rocha M, Mehta S, Ferguson ND, Hall R, Fowler R, Burns K, Qushmaq I, Ostermann M, Heels-Ansdell D, Cook D; PROTECT Research Coordinators; PROTECT Investigators; Canadian Critical Care Trials Group; Australian, New Zealand Intensive Care Society Clinical Trials Group.

J Crit Care. 2013 Feb;28(1):28-39. doi: 10.1016/j.jcrc.2012.08.005. Epub 2012 Oct 22.

PMID:
23089679
11.

A team-based approach to warfarin management in long term care: a feasibility study of the MEDeINR electronic decision support system.

Papaioannou A, Kennedy CC, Campbell G, Stroud JB, Wang L, Dolovich L, Crowther MA; Improving Prescribing in Long Term Care Investigators.

BMC Geriatr. 2010 Jun 10;10:38. doi: 10.1186/1471-2318-10-38.

12.

Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study.

Crowther MA, Garcia D, Ageno W, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Schulman S, Kovacs M, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

Thromb Haemost. 2010 Jul;104(1):118-21. doi: 10.1160/TH09-12-0822. Epub 2010 May 10.

PMID:
20458438
13.

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

Ann Intern Med. 2009 Mar 3;150(5):293-300.

PMID:
19258557
14.

Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review.

Verhovsek M, Motlagh B, Crowther MA, Kennedy C, Dolovich L, Campbell G, Wang L, Papaioannou A.

BMC Geriatr. 2008 Jul 3;8:13. doi: 10.1186/1471-2318-8-13.

Supplemental Content

Loading ...
Support Center